Skip to main content

Table 1 Clinical, background, and laboratory characteristics of the participants (n = 311)

From: Decline in eGFR and mortality among type II diabetic patients: a 3-year prospective cohort study from Palestine

Variables

Baseline

n (%)

Age in years(Mean ± SD)

61 ± 10.1

Gender

 

 Male

152 (48.9%)

 Female

159 (51.1%)

Smoker

96 (31.8%)

BMI(Mean ± SD)

32.8 ± 5.8

HTN

241 (79.8%)

HTN Duration in years(Mean ± SD)

8.9 ± 7.6

DM Duration in years(Mean ± SD)

12.4 ± 8.2

eGFR(Mean ± SD)

73.7 ± 23.9

eGFR level(ml/min/1.73 m²)

 

 ≥ 90

89 (28.6%)

 60–89

138 (44.4%)

 < 60

84 (27%)